大行评级｜花旗：上调环球医疗目标价至6.9港元 上调每股盈利预测

Group 1 - Citi updated its valuation model for Universal Medical following the release of its first-half results, raising the earnings per share forecasts for 2025, 2026, and 2027 by 4%, 6%, and 4% respectively, reflecting a decrease in financing costs and an expansion in the net present value of the financing lease business [1] - The target price for Universal Medical was increased from HKD 6.3 to HKD 6.9, with a "Buy" rating assigned [1]